Log In
Wednesday 20th June 2018

NICE approve new arthritis drug

24th October 2007

A new drug has been approved for the treatment of rheumatoid arthritis (RA).

The National Institute for Health and Clinical Excellence (NICE) has recommended that adalimumab should be offered to adults with rheumatoid arthritis that have already tried two disease-modifying anti-rheumatic drugs. Arthritis Care welcomed the new NICE guidelines and said that the drugs were “life changing and in some cases life saving� while NICE chief executive Andrew Dillon said that the approval of adalimumab, along with two other drugs, etanercept and infliximab, was good news for patients with RA.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018